NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
06/05/2025
Voltar para busca
Dado oficial do USPTO
RETHINKDEPRESSION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
07/05/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 41, 42, 44
Data de depósito
25/05/2017
Data de registro
13/11/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/04/2025
Última transação
07/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
704
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
Valby, DK
Examinador
CARLYLE, SHAUNIA
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the words "RETHINKDEPRESSION" with a thought cloud over the letter "I." The word "RETHINK" is in blue; the word "DEPRESSION" and the thought cloud are in red. The color white is not claimed as a feature of the mark and represents background.
Titulares e representantes
Titulares
H. Lundbeck A/S
H. Lundbeck A/S
Representantes
Maren C. Perry King & Spalding LLP
Classificação técnica
Classes Nice
Classe 5Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ingenerated by or acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementiaAlzheimer's disease and disorderdizzinessseizuresstrokedepressioncognitive impairmentcognitive disorders and diseasesmood disorderspsychosisanxietyapathyepilepsyLennox-Gastaut syndrome (LGS)sclerosisporphyriaHuntington's disease and disorderinsomniaParkinson's disease and disorderfallsmovement disorders and diseasesschizophreniabipolar disorder and diseaseADHDoncologypainalcoholism and dependency; medical preparationssubstancesreagents and diagnostic agents for medical purposes
Classe 41
Education servicesarranging and conducting seminarsconferencessymposiumsworkshops and courses in the field of medical research and developmentscienceclinical studiestests and trialsdiagnosticmedicinepharmaceuticalsdisordersdiseasestreatment and prevention; educational and training services in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing the aforementioned services electronicallyon-linevia cable or Internet or other electronic media; arranging and conducting expert forumsincluding on-line in the form of seminarsconferencessymposiumsworkshops and courses in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing on-line training programs in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing on-line publicationsbooksreportsbrochuresbookletsleafletspatient information leafletsmagazinesjournalsteaching and educational material in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders
Classe 42
Scientific and technological servicesresearch and design in the field of pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; medical and scientific researchconducting clinical trials for others; clinical studies tests and trials; industrial analysis and research in the field of research and development relating to the treatment and prevention of diseases and disorders of the central nervous system; pharmaceutical research and development services; medical research; providing information in the field of research and development related to the treatment and prevention of central nervous system diseases and disorders
Classe 44
Medical and therapeutic services relating to the treatment and prevention of brain and central nervous system diseases and disorders; healthcare servicesclinical healthcare; medicalclinicaltherapeutic clinical services in the field of brain and central nervous system diseases and disorders; healthcare information services; medical services in the field of psychiatry and psychology and medical treatment of central nervous system related diseases and disorders; medical advice related to the treatment of central nervous system diseases and disorders; healthcare and medical services related to the treatment and prevention of central nervous system and brain diseases and disorders; providing medical and medicinal information in the field of diagnosticsmedicine and pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; providing on-line medical informationdata and analyses designed to provide patients and clients with customized information regarding diagnosis and treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
15/04/2025
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
15/04/2025
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
15/04/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/04/2025
ES8R
TEAS SECTION 8 RECEIVED
08/11/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
08/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/03/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
22/03/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
22/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/03/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
13/11/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/08/2018
PUBO
PUBLISHED FOR OPPOSITION
28/08/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/08/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
23/07/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
20/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
16/07/2018
ALIE
ASSIGNED TO LIE
16/07/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/07/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
16/07/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/07/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/01/2018
GNRT
NON-FINAL ACTION E-MAILED
24/01/2018
CNRT
NON-FINAL ACTION WRITTEN
24/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2017
GNRT
NON-FINAL ACTION E-MAILED
10/07/2017
CNRT
NON-FINAL ACTION WRITTEN
10/07/2017
DOCK
ASSIGNED TO EXAMINER
03/07/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2017
NWAP
NEW APPLICATION ENTERED
29/05/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RETHINKDEPRESSION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.